Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study

American Journal of Clinical Nutrition

Volumn 100, Issue 3, 2014, Pages 891-900

  Jacobs, Simone ^a,f   Kröger, Janine ^a,f   Floegel, Anna ^a   Boeing, Heiner ^a   Drogan, Dagmar ^a   Pischon, Tobias ^c   Fritsche, Andreas ^d,f   Prehn, Cornelia ^b   Adamski, Jerzy ^b   Isermann, Berend ^e   Weikert, Cornelia ^a   Schulze, Matthias B ^a,f  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FETUIN A; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHENYLALANINE; PHOSPHATIDYLCHOLINE; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; COFFEE;

ADULT; ARTICLE; COFFEE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; AGED; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; FEEDING BEHAVIOR; FOLLOW UP; GERMANY; INCIDENCE; MULTICENTER STUDY; RISK; SEX DIFFERENCE; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; COFFEE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK; SEX FACTORS; YOUNG ADULT;

EID: 84907371657     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.080317     Document Type: Article

References (46)

1. Grigg D. The worlds of tea and coffee: Patterns of consumption. GeoJournal 2002;57:283-94. (Pubitemid 38394025)
2. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 2014;53:25-38.
3. Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 2012;66:872-7.
4. Saito M, Nemoto T, Tobimatsu S, Ebata M, Le Y, Nakajima K. Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial. J Nutr Metab 2011;2011:146865.
5. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 2011;10:93.
6. Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, Koenig W, Sundvall J, Bidel S, Kuha S, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010;91:950-7.
7. Gavrieli A, Yannakoulia M, Fragopoulou E, Margaritopoulos D, Chamberland JP, Kaisari P, Kavouras SA, Mantzoros CS. Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men. J Nutr 2011;141:703-7.
8. Wedick NM, Mantzoros CS, Ding EL, Brennan AM, Rosner B, Rimm EB, Hu FB, van Dam RM. The effects of caffeinated and decaffeinated coffee on sex hormone-binding globulin and endogenous sex hormone levels: a randomized controlled trial. Nutr J 2012;11:86.
9. Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 2004;255:89-95. (Pubitemid 38121926)
10. Goto A, Song Y, Chen BH, Manson JE, Buring JE, Liu S. Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Diabetes 2011;60:269-75.
11. Boeing H, Wahrendorf J, Becker N. EPIC-Germany: a source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999;43:195-204.
12. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008;57:2762-7.
13. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26:S59-70. (Pubitemid 27129690)
14. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-8. (Pubitemid 36126226)
15. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AFH. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetes 2003;52:812-7. (Pubitemid 36323590)
16. Ford ES, Schulze MB, Bergmann MM, Thamer C, Joost HG, Boeing H. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 2008;31:1138-43.
17. Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, Fritsche A, Haring HU, Hrabe de Angelis M, Peters A, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013;62:639-48.
18. Montonen J, Drogan D, Joost HG, Boeing H, Fritsche A, Schleicher E, Schulze MB, Pischon T. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 2011;26:29-38.
19. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-63.
20. Palmer-Toy DE, Szczepiorkowski ZM, Shih V, Van Cott EM. Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrated whole blood. Clin Chem 2001;47:1704-7. (Pubitemid 32781588)
21. Römisch-Margl W, Prehn C, Bogumil R, Röhring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics 2012;8:133-42.
22. Floegel A, von Ruesten A, Drogan D, Schulze MB, Prehn C, Adamski J, Pischon T, Boeing H. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam. Eur J Clin Nutr 2013;67:1100-8.
23. Floegel A, Drogan D, Wang-Sattler R, Prehn C, Illig T, Adamski J, Joost HG, Boeing H, Pischon T. Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PLoS ONE 2011;6:e21103.
24. Bergmann MM, Bussas U, Boeing H. Follow-up procedures in EPIC-Germany: data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 1999;43:225-34.
25. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)- Potsdam study. Am J Clin Nutr 2006;84:427-33. (Pubitemid 44699156)
26. Bergmann MM, Jacobs E, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur J Epidemiol 2004;19:411-6. (Pubitemid 39012753)
27. Balk L, Hoekstra T, Twisk J. Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol 2009;24:203-9.
28. Maki T, Pham NM, Yoshida D, Yin G, Ohnaka K, Takayanagi R, Kono S. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women. Clin Chem Lab Med 2010;48:849-54.
29. Floegel A, Wientzek A, Bachlechner U, Jacobs S, Drogan D, Prehn C, Adamski J, Krumsiek J, Schulze MB, Pischon T, et al. Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study. Int J Obes (Lond) 2014;10:39.
30. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
31. Prentice RL, Self SG. Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. Stat Med 1988;7:275-87.
32. Hoffmann K, Pischon T, Schulz M, Schulze MB, Ray J, Boeing H. A statistical test for the equality of differently adjusted incidence rate ratios. Am J Epidemiol 2008;167:517-22. (Pubitemid 351323318)
33. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
34. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009;5:150-9.
35. Carson CA, Caggiula AW, Meilahn EN, Matthews KA, Kuller LH. Coffee consumption: relationship to blood lipids in middle-aged women. Int J Epidemiol 1994;23:523-7. (Pubitemid 24214856)
36. Miyake Y, Kono S, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S. Relationship of coffee consumption with serum lipids and lipoproteins in Japanese men. Ann Epidemiol 1999;9:121-6. (Pubitemid 29072770)
37. Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure: results from a Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol 1989;42:877-84. (Pubitemid 19231954)
38. Weigel T. Daten und Fakten zur Kaffeeindustrie. [Data and facts about the coffee industry.] Statista, 2011 (in German). Available from: http://de.statista.com/statistik/faktenbuch/151/a/branche-industrie-markt/ lebensmittelindustrie/ kaffeeindustrie/ (cited 5 July 2013).
39. van Dusseldorp M, Katan MB, van Vliet T, Demacker PN, Stalenhoef AF. Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb 1991;11:586-93.
40. Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 2011;300:E122-33.
41. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 2009;58:2429-43.
42. Altmaier E, Kastenmuller G, Romisch-Margl W, Thorand B, Weinberger KM, Adamski J, Illig T, Doring A, Suhre K. Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Mol Nutr Food Res 2009;53:1357-65.
43. Cole LK, Vance JE, Vance DE. Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim Biophys Acta 2012;1821:754-61.
44. Tunnicliffe JM, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008;33:1290-300.
45. Cole SR, Hernan MA. Fallibility in estimating direct effects. Int J Epidemiol 2002;31:163-5. (Pubitemid 34284920)
46. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-95. (Pubitemid 8112070)